Table: Immuno Biological Lab -2023/24 group results

Immuno-Biological Laboratories

14/05/2024 07:30

May 14 (Reuters)- 
          Immuno Biological Laboratories Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2024    Mar 31, 2023   Mar 31, 2025     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          816 mln         794 mln        925 mln                
               (+2.8 pct)      (+22.7 pct)    (+13.3 pct)              
  Operating      104 mln         57 mln         120 mln                
               (+82.5 pct)                    (+15.1 pct)              
  Recurring      125 mln      loss 149 mln      120 mln                
                                              (-4.3 pct)               
  Net
  Net            186 mln      loss 289 mln      115 mln                
                                              (-38.4 pct)              
  EPS           20.05 yen    loss 31.10 yen    12.30 yen               
  Ann Div          NIL             NIL            NIL                  
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div          NIL             NIL            NIL                  
  
  NOTE - Immuno Biological Laboratories Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T